AureoGen Biosciences

AureoGen is a research-based biotech company with a focus on discovery and production of commercially and clinically important cyclic peptide-based drugs, through genetic engineering of cyclic peptide producing organisms (as an alternative to complex and expensive synthetic chemistry methods). AureoGen’s business is centered on generation intellectual property, both through discovery of novel genes, molecules and organisms and through development of novel technology and engineered organisms.